Forsta Ap-Fonden’s Eli Lilly & Co Position
Does Forsta Ap-Fonden own Eli Lilly & Co (LLY)? Not currently — the last reported position was 230.6K shares worth $248M in Q4 2025; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$248M
Q4 2025
Shares
230.6K
% of Portfolio
+1.48%
Quarters Held
28
position exited
Position History LLY
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q4 2025 | 230.6K | $248M | +1.48% |
| Q3 2025 | 233.4K | $178M | +1.06% |
| Q2 2025 | 223.1K | $174M | +1.14% |
| Q1 2025 | 216.3K | $179M | +1.35% |
| Q4 2024 | 210.4K | $162M | +1.15% |
| Q3 2024 | 212.0K | $188M | +1.44% |
| Q2 2024 | 194.3K | $176M | +1.56% |
| Q1 2024 | 212.2K | $165M | +1.40% |
| Q4 2023 | 197.5K | $115M | +1.16% |
| Q3 2023 | 193.6K | $104M | +1.16% |
| Q2 2023 | 193.2K | $91M | +0.97% |
| Q1 2023 | 198.5K | $68M | +0.80% |
| Q4 2022 | 214.9K | $79M | +0.89% |
| Q3 2022 | 183.7K | $59M | +0.73% |
| Q2 2022 | 164.0K | $53M | +0.69% |
| Q1 2022 | 168.0K | $48M | +0.55% |
| Q4 2021 | 193.1K | $53M | +0.54% |
| Q3 2021 | 206.2K | $48M | +0.54% |
| Q2 2021 | 178.9K | $41M | +0.48% |
| Q1 2021 | 169.7K | $32M | +0.44% |
| Q4 2020 | 165.8K | $28M | +0.42% |
| Q3 2020 | 149.1K | $22M | +0.46% |
| Q2 2020 | 150.7K | $25M | +0.65% |
| Q1 2020 | 124.6K | $17M | +0.62% |
| Q4 2019 | 262.4K | $34M | +1.72% |
| Q3 2019 | 286.5K | $32M | +1.34% |
| Q2 2019 | 254.9K | $28M | +1.27% |
| Q1 2019 | 257.9K | $33M | +1.47% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Forsta Ap-Fonden’s full portfolio or all institutional holders of LLY.